A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis
Public ClinicalTrials.gov record NCT02223039. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of AbGn-168H Administered by Intravenous Infusion to Patients With Moderate to Severe Chronic Plaque Psoriasis (Randomised, Double-blind, Placebo-controlled)
Study identification
- NCT ID
- NCT02223039
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- AbGenomics B.V Taiwan Branch
- Industry
- Enrollment
- 50 participants
Conditions and interventions
Conditions
Interventions
- AbGn-168H Biological
- Placebo Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2014
- Primary completion
- Nov 30, 2014
- Completion
- Jan 31, 2015
- Last update posted
- Apr 13, 2016
2014 – 2015
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alliance Dermatology & MOHS Center, PC | Phoenix | Arizona | 85032 | — |
| Northwest AR Clinical Trials Center, PLLC. | Rogers | Arkansas | 72758 | — |
| Renstar Medical Research | Ocala | Florida | 34471 | — |
| Progressive Medical Research | Port Orange | Florida | 32127 | — |
| Progressive Medical Research | Tampa | Florida | 33609 | — |
| DawesFretzin Clinical Research Group, LLC. | Indianaopolis | Indiana | 46256 | — |
| Comprehensive Clinical Research | Berlin | New Jersey | 08009 | — |
| Manhattan Medical Research Practice PLLC | New York | New York | 10016 | — |
| Skin Search of Rochester, Inc. | Rochester | New York | 14623 | — |
| High Point Clinical Trials Cente | High Point | North Carolina | 27265 | — |
| Wake Research Associates | Raleigh | North Carolina | 27612 | — |
| Lynn Health Science Institute | Oklahoma City | Oklahoma | 73112 | — |
| Radiant Research, Inc. | Greer | South Carolina | 29650 | — |
| Suzanne Bruce and Associates, P.A., The Center for Skin Research | Katy | Texas | 77494 | — |
| University of Utah Dermatology School of Medicine Dermatology 4A330 | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02223039, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 13, 2016 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02223039 live on ClinicalTrials.gov.